Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124688702 | 12468870 | 2 | F | 20160623 | 20160615 | 20160707 | EXP | JP-JNJFOC-20160606119 | JANSSEN | SAKURAI Y, NAMBA K, MIZUUCHI K, NOMURA T, ISHIDA S. A CASE OF SEVERE PANUVEITIS ASSOCIATED WITH PSORIASIS VULGARIS SUCCESSFULLY TREATED WITH INFLIXIMAB. CASE REPORTS IN OPHTHALMOLOGY 2016;7 (1):191-194. | 27.00 | YR | A | M | Y | 0.00000 | 20160707 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124688702 | 12468870 | 1 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | INFUSED 2 AND 6 WEEKS FOLLOWING THE FIRST INFUSION AND EVERY 8 WEEKS THEREAFTER | U | U | 0 | 5 | MG/KG | LYOPHILIZED POWDER | |||||
| 124688702 | 12468870 | 2 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | INFUSED 2 AND 6 WEEKS FOLLOWING THE FIRST INFUSION AND EVERY 8 WEEKS THEREAFTER | U | U | 103772 | 5 | MG/KG | LYOPHILIZED POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124688702 | 12468870 | 1 | Psoriasis |
| 124688702 | 12468870 | 2 | Uveitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124688702 | 12468870 | OT |
| 124688702 | 12468870 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124688702 | 12468870 | Cataract | |
| 124688702 | 12468870 | Off label use | |
| 124688702 | 12468870 | Product use issue | |
| 124688702 | 12468870 | Vitreous haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |